Cultural Thesis Scan
Cultural Thesis Scan
Violent dispersion: HIMS is exploding (RSI 70.9, +58.1% 30D, +23.7% 7D, +28.1% vs SMA20 — the runaway leader) while BRBR is in total collapse (RSI 47.5 but -84% from high, -45% 3M, broken thesis). CROX (RSI 63.1, +25.7% 30D, +61% 3M, strong-up, near high) is the second winner. LULU remains the deep-value casualty (RSI 35.7, -54% from high, collapse, lowest RSI). NKE (-44% from high, downtrend) and DPZ (-37% from high, collapse) are still broken. SBUX (RSI 54) is the lone quiet-uptrend stabilizer. No oversold (<30) names; LULU 35.7 is the floor of the book.
Latest bar Thursday 2026-06-18 (Fri 06-19 Juneteenth, closed). NKE/LULU/SBUX/DPZ/CROX 2d stale (06-16/06-17) — flagged inline. All US-listed.
Quick Snapshot
| Signal | Reading |
|---|---|
| Overall | 🟡 Extreme dispersion — two runaway winners (HIMS +58% 30D, CROX +61% 3M near highs) against a wall of broken consumer names (BRBR -84% from high, LULU -54%, NKE -44%, DPZ -37%). No middle |
| Key insight | The cultural-arbitrage book has fully split: GLP-1/telehealth (HIMS) and footwear-comeback (CROX) are the live trends; the athleisure/restaurant/protein names (LULU/NKE/DPZ/BRBR) are broken theses, not dips. BRBR's thesisState is explicitly "broken." Only SBUX is a quiet hold |
Price Table
| Stock | Price | RSI | vs SMA20 | 7D% | 30D% | 3M% | 52wkHi% | Signal |
|---|---|---|---|---|---|---|---|---|
| HIMS | $35.47 | 70.9 | +28.1% | +23.68% | +58.07% | +46.81% | -49.64% | 🔒 Hold (extended) |
| CROX | $124.53 | 63.1 | +4.3% | -2.94% | +25.65% | +61.12% | -3.65% | 🔒 Hold (06-17, 2d stale) |
| SBUX | $101.68 | 54.0 | +1.7% | +3.62% | -4.62% | +4.82% | -6.61% | 🔒 Hold (06-16, 2d stale) |
| NKE | $45.04 | 52.6 | +1.2% | +0.11% | +6.76% | -17.55% | -43.82% | 🔍 Watch (06-16, 2d stale) |
| BRBR | $9.46 | 47.5 | +7.8% | +7.39% | +6.41% | -45.44% | -84.35% | ❌ Don't Buy |
| DPZ | $314.36 | 47.4 | +0.7% | -3.07% | +1.14% | -15.72% | -37.00% | 🔍 Watch (06-17, 2d stale) |
| LULU | $115.50 | 35.7 ↓ | -6.6% | -3.53% | -3.96% | -27.48% | -54.21% | 🔍 Watch (06-16, 2d stale) |
TSLA is also on this watchlist (RSI 48.1, $400.49, -19.7% from high, pullback) — covered in the EV/clean-energy scan; range-bound, hold.
Tier Analysis
Runaway Leaders / Hold (RSI 63-71): HIMS (RSI 70.9, +58.1% 30D, +23.7% 7D, +28.1% vs SMA20, +33.1% vs SMA50 — GLP-1/telehealth exploding; the runaway name, but still -49.6% from its own 52wk high and now overbought/extended), CROX (RSI 63.1, +25.7% 30D, +61.1% 3M, strong-up, golden cross, only -3.65% from high — the footwear-comeback name in a clean uptrend). HIMS is the momentum story but extended; CROX is the healthier trend.
Quiet Hold (RSI 54): SBUX (RSI 54.0, strong-up, golden cross, +4.8% 3M, -6.6% from high) — the lone stabilizer; coffee-comeback basing in a quiet uptrend.
Broken / Watch (RSI 47-53): NKE (RSI 52.6, -44% from high, -17.6% 3M, downtrend, death cross, +6.8% 30D bounce), DPZ (RSI 47.4, -37% from high, -15.7% 3M, collapse, death cross), BRBR (RSI 47.5, -84% from high, -45% 3M, collapse, thesisState broken — the +6.4% 30D bounce is noise on a destroyed chart). These are broken theses; the mid-RSI readings hide the damage.
Deep Casualty / Watch (RSI 36): LULU (RSI 35.7, -54% from high, -27.5% 3M, collapse, death cross, alpha1y -77 — the lowest RSI and the athleisure deep-value casualty). Not oversold (<30), but structurally broken — a falling knife, not a dip.
Entry Zones
| Stock | Price | RSI | 30D% | Setup |
|---|---|---|---|---|
| CROX | $124.53 | 63.1 | +25.65% | Healthiest trend — strong-up, +61% 3M, only -3.65% from high; -2.9% 7D pullback; watch for SMA20 hold ($119) to add (06-17, 2d stale) |
| SBUX | $101.68 | 54.0 | -4.62% | Quiet uptrend, basing, -6.6% from high; the lower-risk cultural hold; watch SMA20 ($100) (06-16, 2d stale) |
| LULU | $115.50 | 35.7 ↓ | -3.96% | Lowest RSI but collapse + death cross, -54% from high; NOT an oversold dip — wait for a trend turn, not a value buy (06-16, 2d stale) |
| HIMS | $35.47 | 70.9 | +58.07% | Runaway leader but RSI 70.9, +28% vs SMA20 — extended; do not chase, watch for a pullback to SMA20 ($28) |
Action Matrix
| Action | Stocks | Why |
|---|---|---|
| 🔒 HOLD | HIMS, CROX | The two live cultural trends; HIMS extended (don't chase), CROX clean uptrend |
| 🔒 HOLD | SBUX | Quiet uptrend stabilizer, RSI 54 |
| 🔍 WATCH | NKE, DPZ, LULU | Broken consumer theses (-37 to -54% from highs); no floors confirmed |
| ❌ DON'T BUY | BRBR | -84% from high, collapse, thesisState explicitly broken |
What Changed
- HIMS exploded — RSI 70.9, +58.1% 30D, +23.7% 7D, +28.1% vs SMA20; the GLP-1/telehealth name is the runaway leader (though still -49.6% from its own high — a sharp recovery off a deep base)
- CROX confirmed uptrend — RSI 63.1, +61.1% 3M, +25.7% 30D, only -3.65% from high; the footwear-comeback in clean strength
- BRBR thesis broke — thesis "broken," -84% from high, -45% 3M; the protein-shake cultural thesis is over
- LULU still the deep casualty — RSI 35.7 (book low), -54% from high, collapse + death cross
- NKE/DPZ remain broken — NKE -44% from high (downtrend), DPZ -37% (collapse); the +6.8%/+1.1% 30D moves are noise
- SBUX stabilizing — RSI 54, strong-up, basing; the lone quiet hold
- No oversold names — lowest RSI is LULU 35.7; the broken names sit at mid-RSI on collapse regimes
The Gold
Key Discoveries
| Discovery | Implication |
|---|---|
| Cultural book fully split — HIMS/CROX winning, LULU/NKE/DPZ/BRBR broken | The arbitrage worked on the winners and failed on the laggards; treat them as separate, not one "consumer" trade |
| HIMS +58% 30D but still -49.6% from its own high | A violent recovery off a deep base, not a fresh breakout — the trend is young but extended short-term |
| BRBR thesisState explicitly "broken" | The system flagged the thesis as dead — don't re-litigate the +6% 30D bounce as a turn |
Mistakes (Don't Repeat)
| Mistake | Lesson |
|---|---|
| Buying LULU/NKE on "-50% from high = value, cultural brand" | Both collapse/downtrend + death cross; brand strength ≠ chart floor; falling knives |
| Chasing HIMS at RSI 70.9 / +28% vs SMA20 | Extended runaway; entry risk asymmetric — wait for digestion to SMA20 |
Open Questions
Related
10 eventsNo direct external sources are attached to this read.